Regulation & law · 29/09/1995Updated: 10/18/2026 · 1 min read
FDA Withdraws Approval of 17 New Drug Applications
Summary
The US Food and Drug Administration (FDA) has withdrawn approval of 17 new drug applications (NDAs) following notification from the applicants that the corresponding drug products are no longer commercially available.
Original source language: Federal Register — All DocumentsOpen original release →